MiR-31-5p在癌症中的研究进展

摘要/Abstract

关键词: miRNAs, miR-31-5p, 肿瘤, 非编码 RNA

中图分类号:

R730

姜平, 姜永森, 耿学丽. MiR-31-5p在癌症中的研究进展[J]. 承德医学院学报, 2024, 41(5): 413-417.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: http://tougao.cdmc.edu.cn:8088/CN/

http://tougao.cdmc.edu.cn:8088/CN/Y2024/V41/I5/413

[1] He B, Zhao Z, Cai Q, et al.MiRNA-based biomarkers, therapies, and resistance in Cancer[J]. International Journal of Biological Sciences, 2020, 16(14): 2628-2647.
[2] Yu T, Ma P, Wu D, et al.Functions and mechanisms of microRNA-31 in human cancers[J]. Biomedicine Pharmacotherapy Biomedecine Pharmacotherapie, 2018, 108: 1162-1169.
[3] 黎爽,彭洪,龚磊,等. miR-31-5p通过VPS53介导的自噬对结直肠癌细胞增殖的影响[J]. 结直肠肛门外科,2021,27(5): 453-459.
[4] Liu C, Wu W, Chang W, et al.miR-31-5p-DMD axis as a novel biomarker for predicting the development and prognosis of sporadic early-onet colorectal cancer[J]. Oncology Letters, 2022, 23(5): 157.
[5] Mi B, Li Q, Li T, et al.High miR-31-5p expression promotes colon adenocarcinoma progression by targeting TNS1[J]. Aging, 2020, 12(8): 7480-7490.
[6] Lai YH, Liu H, Chiang WF, et al.MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2[J]. Theranostics, 2018, 8(2): 486-504.
[7] 景奉洋. MiRNA-31-5p通过调节AK2-AIF信号轴促进口腔癌进展[D]. 合肥:安徽医科大学,2022.
[8] Zhao J, Xu H, Duan Z, et al.miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway[J]. Cancer Management and Research, 2020, 12: 6679-6694.
[9] Zhao G, Han C, Zhang Z, et al.Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line[J]. Biochemical and Biophysical Research Communications, 2017, 490(2): 371-377.
[10] Wen J, Xiong K, Aili A, et al.PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination[J]. Theranostics, 2020, 10(12): 5322-5340.
[11] Shen X, Lei J, Du L. miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC[J]. Experimental and Therapeutic Medicine, 2020, 19(1): 375-383.
[12] Li Y, Quan J, Chen F, et al.MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)[J]. Biomedicine Pharmacotherapy Biomedecine Pharmacotherapie, 2019, 111: 517-526.
[13] He J, He J, Min L, et al.Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma[J]. International Journal of Cancer, 2020, 146(4): 1052-1063.
[14] Zhu C, Wang S, Zheng M, et al.miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis[J]. Strahlenther Onkol, 2022, 198(3): 304-314.
[15] Zhu B, Cao X, Zhang W, et al.MicroRNA-31-5p enhances the Warburg effect via targeting FIH[J]. FASEB J, 2019, 33(1): 545-556.
[16] Chi XJ, Wei LL, Bu Q, et al.Identification of high expression profiles of miR-31-5p and its vital role in lung squamous cell carcinoma: a survey based on qRT-PCR and bioinformatics analysis[J]. Translational Cancer Research, 2019, 8(3): 788-801.
[17] Davenport ML, Echols JB, Silva AD, et al.miR-31 Displays Subtype Specificity in Lung Cancer[J]. Cancer Research, 2021, 81(8): 1942-1953.
[18] Xu H, Ma J, Zheng J, et al.MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR[J]. Clinical Laboratory, 2016, 62(4): 711-718.
[19] Yu F, Liang M, Huang Y, et al.Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling[J]. J Exp Clin Cancer Res, 2021, 40(1): 179.
[20] Ren J.Intermittent hypoxia BMSCs-derived exosomal miR-31-5p promotes lung adenocarcinoma development via WDR5-induced epithelial mesenchymal transition[J]. Sleep Breath,2023,27(4): 1399-1409.
[21] Peng H, Wang L, Su Q, et al.MiR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB[J]. Biomedicine Pharmacotherapy Biomedecine Pharmacotherapie, 2019, 109: 208-216.
[22] Yuan Y, Wang Z, Chen M, et al.Macrophage-Derived Exosomal miR-31-5p Promotes Oral Squamous Cell Carcinoma Tumourigenesis Through the Large Tumor Suppressor 2-Mediated Hippo Signalling Pathway[J]. Journal of Biomedical Nanotechnology, 2021, 17(5): 822-837.
[23] 余杰,王旸,贾彦召,等. miR-31-5p通过调控TNS1抑制乳腺癌细胞生物学行为及放疗抵抗的分子机制[J].中国肿瘤生物治疗杂志,2018,25(10):1013-1020.
[24] Luo LJ, Yang F, Ding JJ, et al.MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer[J]. Gene, 2016, 594(1): 47-58.
[25] Chen Y, Ji S, Ying J, et al.KRT6A expedites bladder cancer progression, regulated by miR-31-5p[J]. Cell Cycle, 2022, 21(14): 1479-1490.
[26] 龚年金,李光才,张明华,等. lncRNA MAGI2-AS3下调miR-31-5p抑制肺腺癌细胞的增殖、迁移、侵袭并促进凋亡[J]. 中华细胞与干细胞杂志(电子版),2020,10(4):204-212.
[27] Cheng X, Sha M Jiang W, et al. LINC00174 Suppresses Non-Small Cell Lung Cancer Progression by Up-Regulating LATS2 via Sponging miR-31-5p[J]. Cell J, 2022, 24(3): 140-147.
[28] Du YL, Liang Y, Shi GQ, et al.LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer[J]. Experimental Cell Research, 2020, 395(1): 112176.
[29] Jing H, Shi Dai J, Wei Z, et al.Long non-coding RNA LOC554202 promotes acquired gefitinib resistance in non-small cell lung cancer through upregulating miR-31 expression[J]. J Cancer, 2019, 10(24): 6003-6013.
[30] Dong L, Ying X, Qi Y, et al.Long Non-Coding RNA TUG1 Promotes Cell Proliferation and Inhibits Cell Apoptosis, Autophagy in Clear Cell Renal Cell Carcinoma via MiR-31-5p/FLOT1 Axis[J]. Onco Targets Ther,2020, 13: 5857-5868.
[31] Yi D, Zhang D, He J.Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis[J]. Cell Cycle, 2021, 20(24): 2619-2637.
[32] Wang J, Jia J, Zhou L.Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis[J]. Neoplasma, 2020,67(6): 1279-1292.
[33] Zhang W, Zhou X, Tang Z, et al.Knockdown of lncRNA SNHG16 Attenuates the Proliferation and Radioresistance of Nasopharyngeal Carcinoma Cells by Mediating miR-31-5p/SFN Axis[J]. Radiation Research, 2022, 199(2): 124-131.
[34] Alkan AH, Akgül B.Endogenous miRNA Sponges[J]. Methods in Molecular Biology, 2022, 2257: 91-104.
[35] Dykes IM, Emanueli C.Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA[J]. Genomics, Proteomics Bioinformatics, 2017, 15(3): 177-186.
[36] Bi J, Liu H, Cai Z, et al.Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis[J]. Aging, 2018, 10(8): 1964-1976.
[37] Liu Z, Wang R, Zhu G.Circ-0035483 Functions as a Tumor Promoter in Renal Cell Carcinoma via the miR-31-5p-Mediated HMGA1 Upregulation[J]. Cancer Management and Research, 2021, 13: 693-706.
[38] Ren TJ, Liu C, Hou JF, et al.CircDDX17 reduces 5-fluorouracil resistance and hinders tumorigenesis in colorectal cancer by regulating miR-31-5p/KANK1 axis[J]. European Review for Medical and Pharmacological Sciences, 2020, 24(4): 1743-1754.
[39] Wu D, Chen T, Zhao X, et al.HIF1α-SP1 interaction disrupts the circ-0001875/miR-31-5p/SP1 regulatory loop under a hypoxic microenvironment and promotes non-small cell lung cancer progression[J]. J Exp Clin Cancer Res, 2022, 41(1): 156.
[40] Scholtz B, Horváth J, Tar I, et al.Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma[J]. Pathogens, 2022, 11(2): 229.
[41] Kubota N, Taniguchi F, Nyuya A, et al.Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer[J]. Oncology Letters, 2020, 19(4): 2685-2694.
[42] Kiss I, Mlcochova J, Bortlicek Z, et al.Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients[J]. Anticancer Research, 2016, 36(9): 4955-4959.
[43] Yi SJ, Liu P, Chen BL, et al.Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma[J]. Neoplasma, 2019, 66(5): 825-829.
[44] Cao H, Zhang P, Yu H, et al.Extracellular Vesicles-Encapsulated miR-153-3p Potentiate the Survival and Invasion of Lung Adenocarcinoma[J]. Molecules and Cells, 2022, 45(6): 376-387.

MiR-31-5p在癌症中的研究进展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	祝重阳, 程玉, 齐洁敏. TRAIP的研究进展[J]. 承德医学院学报, 2023, 40(6): 505-509.
[2]	冯其柱, 卢曼曼, 陈先志, 孙杰, 张健. 胰腺癌肉瘤1例报道并文献分析[J]. 承德医学院学报, 2023, 40(6): 513-515.
[3]	李金超, 王功臣, 张鸽. 盐酸乙哌立松联合盐酸氨基葡萄糖治疗膝骨关节炎的疗效[J]. 承德医学院学报, 2023, 40(5): 385-389.
[4]	王会杰, 孙珍贵, 赵文英, 耿彪. S100钙结合蛋白A16促进肺腺癌增殖和侵袭进展的研究[J]. 承德医学院学报, 2023, 40(5): 389-394.
[5]	纪凯, 凌潜龙, 朱冰. 细胞自噬调控肿瘤休眠的研究进展[J]. 承德医学院学报, 2023, 40(5): 419-423.
[6]	赵嫣嫣, 梁璐, 郗蕊. 曲妥珠单抗联合SOX方案治疗HER-2阳性晚期胃癌患者的效果[J]. 承德医学院学报, 2023, 40(4): 289-293.
[7]	朱益平, 盛莉莉. 《肿瘤学概论》教学中课程思政元素的挖掘和运用[J]. 承德医学院学报, 2023, 40(4): 347-351.
[8]	李婷, 蔡凤银, 何礼勤. 健康教育联合优质护理对小儿恶性实体肿瘤患儿并发症发生率的影响[J]. 承德医学院学报, 2023, 40(3): 234-237.
[9]	郝梦启, 姬佩雲, 张雅丽. NLRC3、Foxp3在子宫内膜异位症免疫失衡方面的研究进展[J]. 承德医学院学报, 2023, 40(3): 245-249.
[10]	童玲玲, 林燕妮. Doege-Potter综合征1例[J]. 承德医学院学报, 2023, 40(3): 249-251.
[11]	朱敏, 胡菲, 罗杏, 宋辉. ADDIE+360度评估反馈法在肿瘤科护士教学中的应用研究[J]. 承德医学院学报, 2023, 40(3): 259-261.
[12]	赵鹏, 张淑君. 有关喉癌诊断的研究进展[J]. 承德医学院学报, 2023, 40(2): 156-159.
[13]	杨贵丽, 曾会会, 毛燕, 刘春芳. CDIO教学模式在肿瘤科护理实习生临床教学中的应用[J]. 承德医学院学报, 2023, 40(2): 168-171.
[14]	付宜拥, 闫海良, 高龙潭. 益气散结汤对Ⅲ/Ⅳ期食管癌患者疾病控制率及血清相关细胞因子水平的影响[J]. 承德医学院学报, 2022, 39(5): 397-400.
[15]	田朵朵, 邓程, 赵学荣, 王建平, 肖丽君, 丁实. 不同类型肿瘤中IFITM1研究进展[J]. 承德医学院学报, 2022, 39(5): 424-427.